EMEA-002303-PIP01-17

Key facts

Active substance
Etripamil
Therapeutic area
Cardiovascular diseases
Decision number
P/0042/2019
PIP number
EMEA-002303-PIP01-17
Pharmaceutical form(s)
Nasal spray, solution
Condition(s) / indication(s)
Treatment of supraventricular arrhythmias
Route(s) of administration
Intranasal use
Contact for public enquiries
Milestone Pharmaceuticals Inc.

Tel. +1 514330444
E-mail: info@milestonepharma.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating